Tandem Diabetes Care (San Diego, CA) focused on medical devices for diabetes closed a $13.1 Series B financing. Participants include Domain Associates, TPG Biotech and Second Technology Capital Investors.
Seattle Medical Technologies (Seattle, Washington) medical device company focused on diabetes, closed a $21M Series B financing. Participants include Canaan Partners, Skyline Venture Partners, Frazier Healthcare Ventures and Three Arch Partners.
enGene (Canada) protein drug delivery system targeting insulin regulation for diabetics, closed a $6.4M Series A financing. Participants include Saad Investments and Masa Life Science Ventures.
AgaMatrix (Salem, NH) maker of blood glucose monitoring systems that provide results to help users better manage their diabetes closed a $23.7M Series C financing. Participants include Ferrer Freeman & Co.